Glycomic Analysis of Prostate Cancer 5f. Work Unit Number 7. Performing Organization Name(s) and Address(es) 8. Performing Organization Report Number Approved for Public Release; Distribution Unlimited Prostate Cancer, Glycomic Analysis, Health Disparity 16. Security Classification Of: 17. Limitatio

The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation. Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. We are testing the hypothesis that the risk of developing prostate cancer and the aggressiveness of the disease are influenced by protein glycosylation. We postulate that glycobiology contributes to the higher susceptibility of African American men. Newly optimized methods for the glycomic analysis of proteins fractionated into three components are in place. We have assembled the study population and completed the glycomic analysis in two fractions; analysis of the IgA/IgM fraction is under way. We have also evaluated mRNA datasets comparing prostate cancer in African American and Caucasian men. The analysis identified some connections to glycosylation. The final analysis and the interpretation of results is ongoing.

[1]  Haojie Lu,et al.  N-linked glycan changes of serum haptoglobin β chain in liver disease patients. , 2011, Molecular bioSystems.

[2]  C. Lebrilla,et al.  Annotation and structural analysis of sialylated human milk oligosaccharides. , 2011, Journal of proteome research.

[3]  A. Varki,et al.  Biomedical differences between human and nonhuman hominids: potential roles for uniquely human aspects of sialic acid biology. , 2011, Annual review of pathology.

[4]  Pauline M Rudd,et al.  Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation. , 2010, Analytical chemistry.

[5]  Pauline M Rudd,et al.  A systematic approach to protein glycosylation analysis: a path through the maze. , 2010, Nature chemical biology.

[6]  V. Reinhold,et al.  The N-glycome of human plasma. , 2010, Journal of proteome research.

[7]  Mary Ann Comunale,et al.  Linkage Specific Fucosylation of Alpha-1-Antitrypsin in Liver Cirrhosis and Cancer Patients: Implications for a Biomarker of Hepatocellular Carcinoma , 2010, PloS one.

[8]  J. Doré,et al.  The clinical Pseudomonas fluorescens MFN1032 strain exerts a cytotoxic effect on epithelial intestinal cells and induces Interleukin-8 via the AP-1 signaling pathway , 2010, BMC Microbiology.

[9]  Paul C Guest,et al.  Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia. , 2010, Journal of proteome research.

[10]  L. Kiessling,et al.  Chemical approaches to glycobiology. , 2010, Annual review of biochemistry.

[11]  J. Michalski,et al.  Immunoglobulins are the major glycoproteins involved in the modifications of total serum N‐glycome in cirrhotic patients , 2010, Proteomics. Clinical applications.

[12]  T. Rejtar,et al.  Improved sample preparation method for glycan analysis of glycoproteins by CE‐LIF and CE‐MS , 2010, Electrophoresis.

[13]  J. Michalski,et al.  Modifications of human total serum N‐glycome during liver fibrosis–cirrhosis, is it all about immunoglobulins? , 2010, Proteomics. Clinical applications.

[14]  P. Rudd,et al.  Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[15]  I. Rudan,et al.  Variability, heritability and environmental determinants of human plasma N-glycome. , 2009, Journal of proteome research.

[16]  H. Perreault,et al.  Mass spectrometric study of N-glycans from serum of woodchucks with liver cancer. , 2009, Rapid communications in mass spectrometry : RCM.

[17]  Richard D. Cummings,et al.  The repertoire of glycan determinants in the human glycome. , 2009, Molecular bioSystems.

[18]  Joris Delanghe,et al.  GlycoFibroTest Is a Highly Performant Liver Fibrosis Biomarker Derived from DNA Sequencer-based Serum Protein Glycomics*S , 2009, Molecular & Cellular Proteomics.

[19]  Y. Mechref,et al.  Detection of Hepatocellular Carcinoma Using Glycomic Analysis , 2009, Clinical Cancer Research.

[20]  C. Van Steenkiste,et al.  Alteration of protein glycosylation in liver diseases. , 2009, Journal of hepatology.

[21]  Chao Yang,et al.  Comparison of public peak detection algorithms for MALDI mass spectrometry data analysis , 2009, BMC Bioinformatics.

[22]  Yehia Mechref,et al.  High-throughput solid-phase permethylation of glycans prior to mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.

[23]  Yehia Mechref,et al.  Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma. , 2008, Journal of proteome research.

[24]  Mary Ann Comunale,et al.  Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis , 2007, Journal of Virology.

[25]  K. Håkansson,et al.  Electron capture dissociation of oligosaccharides ionized with alkali, alkaline Earth, and transition metals. , 2007, Analytical chemistry.

[26]  Y. Mechref,et al.  Miniaturized separation techniques in glycomic investigations. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[27]  Roger Williams Global challenges in liver disease , 2006, Hepatology.

[28]  Alexandre Louvet,et al.  Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis. , 2006, Glycobiology.

[29]  R. Dwek,et al.  Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: a conserved feature of the thiol ester protein family? , 2006, The Journal of biological chemistry.

[30]  Yehia Mechref,et al.  Solid-phase permethylation of glycans for mass spectrometric analysis. , 2005, Rapid communications in mass spectrometry : RCM.

[31]  Jeffrey S. Morris,et al.  Improved peak detection and quantification of mass spectrometry data acquired from surface‐enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform , 2005, Proteomics.

[32]  D. Ashline,et al.  Congruent strategies for carbohydrate sequencing. 1. Mining structural details by MSn. , 2005, Analytical chemistry.

[33]  C. Bertozzi,et al.  Glycans in cancer and inflammation — potential for therapeutics and diagnostics , 2005, Nature Reviews Drug Discovery.

[34]  D. Harvey Structural determination of N‐linked glycans by matrix‐assisted laser desorption/ionization and electrospray ionization mass spectrometry , 2005, Proteomics.

[35]  James Paulson,et al.  Automatic annotation of matrix‐assisted laser desorption/ionization N‐glycan spectra , 2005, Proteomics.

[36]  L. Klassen,et al.  Immunologic mechanisms of alcoholic liver injury. , 2004, Seminars in liver disease.

[37]  S. Lindgren,et al.  Diagnostic accuracy of alpha(1)-acid glycoprotein fucosylation for liver cirrhosis in patients undergoing hepatic biopsy. , 2002, Clinical chemistry.

[38]  R. Dwek,et al.  Glycosylation and the complement system. , 2002, Chemical reviews.

[39]  H. Adami,et al.  The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis , 2001, Hepatology.

[40]  Pauline M Rudd,et al.  Determining the Structure of Oligosaccharides N‐ and O‐Linked to Glycoproteins , 2000, Current protocols in protein science.

[41]  K. Yasukawa,et al.  Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[42]  D. Hochstrasser,et al.  New alterations of serum glycoproteins in alcoholic and cirrhotic patients revealed by high resolution two-dimensional gel electrophoresis. , 1996, Biochemical and biophysical research communications.

[43]  C. Record,et al.  Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[44]  G. Turner N-glycosylation of serum proteins in disease and its investigation using lectins. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[45]  S. Thompson,et al.  Changes in fucose metabolism associated with heavy drinking and smoking: a preliminary report. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[46]  C. Barsigian,et al.  Carbohydrate abnormalities of N-linked plasma glycoproteins in liver disease. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[47]  N. Kochibe,et al.  Systematic fractionation of oligosaccharides of human immunoglobulin G by serial affinity chromatography on immobilized lectin columns. , 1987, Analytical biochemistry.

[48]  F. I. Lee Immunoglobulins in viral hepatitis and active alcoholic liver-disease. , 1965, Lancet.

[49]  Y. Mechref,et al.  Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. , 2010, Journal of proteome research.

[50]  Haixu Tang,et al.  Automated interpretation of MS/MS spectra of oligosaccharides , 2005, ISMB.

[51]  W. Becker Variations of immunoglobulins in disease. , 1975, Journal of clinical pathology. Supplement.